Tag: Nasdaq:SPRC

SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC

TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announces additional progress in connection with the proposed merger with AutoMax Motors Ltd., a leading vehicles importer and the exclusive importer of Anhui Jianghuai Automobile Group Corp., Ltd.-manufactured electric vehicles in Israel (“AutoMax”).

SciSparc Announces 1-for-21 Reverse Share Split

Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicly held

Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicly held

- A word from our sponsors -

HomeTagsNasdaq:SPRC

Four Michigan students advance to national finals of the Mott Million Dollar Challenge in Flint

Long Beach Community Care Campus Expansion Advances with $10 Million Investment from Centene Foundation and Health Net

Oh!mino Releases New Industry Report on Athletes Replacing Supplement Stacks with All-in-One EAA Formulas

Tag: Nasdaq:SPRC

SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC

SciSparc Announces 1-for-21 Reverse Share Split

Explore

Press Releases

News & Opinion

Living

Others

Follow us